Calcineurin_NN
mutants_NNS
render_VBP
T_NN
lymphocytes_NNS
resistant_JJ
to_TO
cyclosporin_NN
A_NN
._.

The_DT
immunosuppressants_NNS
cyclosporin_NN
A_NN
-LRB-_-LRB-
CsA_NN
-RRB-_-RRB-
and_CC
FK506_NN
have_VBP
been_VBN
widely_RB
used_VBN
to_TO
prevent_VB
and_CC
treat_VB
graft_NN
rejection_NN
after_IN
human_JJ
organ_NN
and_CC
tissue_NN
transplantations_NNS
._.

CsA_NN
and_CC
FK506_NN
associate_VBP
with_IN
intracellular_JJ
binding_VBG
proteins_NNS
-LRB-_-LRB-
i.e._FW
,_,
CsA_NN
with_IN
cyclophilin_NN
A_NN
and_CC
FK506_NN
with_IN
FKBP12_NN
-RRB-_-RRB-
to_TO
form_VB
protein\/drug_NN
complexes_NNS
that_WDT
suppress_VBP
the_DT
immune_JJ
system_NN
by_IN
preventing_VBG
activation_NN
of_IN
T_NN
cells_NNS
in_IN
response_NN
to_TO
antigen_NN
presentation_NN
._.

The_DT
common_JJ
target_NN
of_IN
CsA_NN
and_CC
FK506_NN
is_VBZ
calcineurin_NN
,_,
a_DT
Ca2_JJ
+_CC
\/_JJ
calmodulin-regulated_JJ
,_,
serine\/threonine-specific_JJ
protein_NN
phosphatase_NN
that_WDT
regulates_VBZ
the_DT
nuclear_JJ
import_NN
of_IN
a_DT
transcription_NN
factor_NN
,_,
NF-AT_NN
,_,
required_VBN
for_IN
expression_NN
of_IN
T_NN
cell_NN
activation_NN
genes_NNS
._.

In_IN
previous_JJ
studies_NNS
,_,
we_PRP
identified_VBD
calcineurin_NN
mutations_NNS
that_WDT
block_VBP
binding_NN
by_IN
the_DT
cyclophilin_NN
A\/CsA_NN
or_CC
FKBP12\/FK506_NN
complexes_NNS
and_CC
thereby_RB
render_VBP
yeast_NN
cells_NNS
resistant_JJ
to_TO
the_DT
antifungal_JJ
effects_NNS
of_IN
CsA_NN
or_CC
FK506_NN
._.

In_IN
this_DT
report_NN
,_,
we_PRP
demonstrate_VBP
that_IN
the_DT
corresponding_JJ
mutations_NNS
in_IN
murine_JJ
calcineurin_NN
render_VBP
the_DT
T_NN
cell_NN
receptor_NN
signal_NN
transduction_NN
cascade_NN
CsA_NN
resistant_JJ
in_IN
human_JJ
Jurkat_NN
T_NN
cells_NNS
._.

Our_PRP$
findings_NNS
support_VBP
the_DT
recently_RB
determined_VBN
calcineurin_NN
X-ray_NN
crystal_NN
structure_NN
,_,
provide_VBP
evidence_NN
that_IN
calcineurin_NN
is_VBZ
the_DT
only_RB
CsA-sensitive_JJ
component_NN
limiting_VBG
signaling_NN
from_IN
the_DT
T_NN
cell_NN
receptor_NN
to_TO
the_DT
nucleus_NN
,_,
and_CC
suggest_VBP
a_DT
means_NN
to_TO
render_VB
cells_NNS
and_CC
tissues_NNS
resistant_JJ
to_TO
the_DT
toxic_JJ
side_JJ
effects_NNS
of_IN
CsA_NN
and_CC
FK506_NN
._.

